Haroon, Muhammad <br/><br/>
Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?  [electronic resource] 

 -  Clinical rheumatology  Aug 2011 
 - 1095-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1434-9949 
<br/><br/><label>Standard No.: </label>10.1007/s10067-011-1704-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--complications<br/>Drug Therapy, Combination<br/>Etanercept<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunoglobulin G--adverse effects<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Radiography, Thoracic<br/>Receptors, Tumor Necrosis Factor<br/>Rituximab<br/>Sarcoidosis--diagnosis<br/>Treatment Outcome